Literature DB >> 11992281

Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis.

Tom Coenye1, John J LiPuma.   

Abstract

Burkholderia cepacia complex infections contribute significantly to mortality and morbidity in persons with cystic fibrosis (CF). The aim of this study was to evaluate the use of a novel typing method, multilocus restriction typing (MLRT), for investigation of the global epidemiology of B. cepacia complex genomovar III, the species most commonly encountered in CF. In the MLRT method, variation at several loci is indexed by restriction analysis of polymerase chain reaction-amplified genes. Data obtained by MLRT and pulsed-field gel electrophoresis analysis of a large number of B. cepacia genomovar III isolates (including isolates belonging to epidemic lineages and environmental isolates) show a strong correlation. MLRT extends the utility of isolate genotyping by allowing comparisons of isolates collected in studies of larger scale (both temporal and spatial). The portability of MLRT data will facilitate comparison of data obtained in different laboratories. In addition, data obtained with MLRT can be used in studies of bacterial population structure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992281     DOI: 10.1086/340279

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia.

Authors:  Amanda S Engledow; Enrique G Medrano; Eshwar Mahenthiralingam; John J LiPuma; Carlos F Gonzalez
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

3.  Metabolic profiling of Burkholderia cenocepacia, Burkholderia ambifaria, and Burkholderia pyrrocinia isolates from maize rhizosphere.

Authors:  Chiara Alisi; Giovanna Jona Lasinio; Claudia Dalmastri; AnnaRosa Sprocati; Silvia Tabacchioni; Annamaria Bevivino; Luigi Chiarini
Journal:  Microb Ecol       Date:  2005-11-25       Impact factor: 4.552

4.  Biocide susceptibility of the Burkholderia cepacia complex.

Authors:  Helen Rose; Adam Baldwin; Christopher G Dowson; Eshwar Mahenthiralingam
Journal:  J Antimicrob Chemother       Date:  2009-01-18       Impact factor: 5.790

5.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

6.  Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.

Authors:  Tom Coenye; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom.

Authors:  Jane F Turton; Mary E Kaufmann; Nazim Mustafa; Sonia Kawa; Fiona E Clode; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Genetic relationships between clinical and non-clinical strains of Yersinia enterocolitica biovar 1A as revealed by multilocus enzyme electrophoresis and multilocus restriction typing.

Authors:  Sarita Mallik; Jugsharan S Virdi
Journal:  BMC Microbiol       Date:  2010-05-28       Impact factor: 3.605

9.  Expanded multilocus sequence typing for burkholderia species.

Authors:  Theodore Spilker; Adam Baldwin; Amy Bumford; Chris G Dowson; Eshwar Mahenthiralingam; John J LiPuma
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

10.  Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity.

Authors:  William R Schwan; Craig Dunek; Michael Gebhardt; Kathleen Engelbrecht; Tiffany Klett; Aaron Monte; Joseph Toce; Marc Rott; Thomas J Volk; John J LiPuma; Xue-Ting Liu; Ronald McKelvey
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-21       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.